Once the court approves the agreement, non-adherent creditors will face a 75% reduction in their outstanding balance. The remaining debt will accrue interest based on the TR , currently estimated at 0 ...
Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...